Prospective Study of Predictive Factors of Sustained Remission of Crohn's Disease After Stopping Infliximab.

Trial Profile

Prospective Study of Predictive Factors of Sustained Remission of Crohn's Disease After Stopping Infliximab.

Completed
Phase of Trial: Phase III

Latest Information Update: 01 Jun 2014

At a glance

  • Drugs Infliximab (Primary)
  • Indications Crohn's disease
  • Focus Therapeutic Use
  • Acronyms STORI
  • Most Recent Events

    • 22 Jul 2010 Actual end date (Jul 2010) added as reported by ClinicalTrials.gov.
    • 22 Jul 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 11 Oct 2009 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top